Bulent Dabanlioglu, Ebru Sener, Adalet Ozcicek, Mehmet Aktas, http://orcid.org/0000-0003-1999-7827, Halis Suleyman, Huseyin Kocaturk, Fevzi Bedir, Sevil Karahan Yilmaz

The effect of lutein on vancomycin-induced oxidative kidney damage in rats

Aim: It has been reported that nephrotoxicity is observed in 5-25% of patients during vancomycin use. The part oxidative stress plays in the pathogenesis of vancomycin-induced nephrotoxicity has been demonstrated. Lutein shows antioxidant activity. The purpose of the present study was to evaluate effects experienced by lutein on oxidative kidney damage induced by vancomycin in rats biochemically an histopathologically. Materials and Methods: Oral administration of lutein at a rate of 1mg per kg was performed for the lutein plus vancomycin group (L+VAN) (n=6), whereas saline was administered to the vancomycin (VAN) (n=6) and healthy control (C) (n=6) groups. Sixty minutes after administration of lutein and solvent, 200 mg/kg vancomycin was intraperitoneally injected twice a day to L+VAN and VAN groups. This procedure was repeated for 7 days. Then malondialdehyde (MDA), total glutathione (tGSH), total oxidant system (TOS) and total antioxidant system (TAS) levels have been assessed in kidney tissues; in addition, creatinine and BUN were measured in blood samples. Kidney tissues were also evaluated histopathologically. Results: Significant histopathological damage could be seen in the kidney tissue of the VAN group that increasing MDA and TOS and creatinine and BUN. Histopathological damage was not very significant in the L+VAN group that decreasing MDA, TOS, BUN and creatinine levels. Conclusion: This suggests that lutein may be effective for the treatment of the treatment of vancomycin-associated oxidative kidney damage.

PDF

___

1. Ingram PR, Lye DC, Tambyah PA, et al. Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy. J Antimicrob Chemother 2008;62:168-71.
2. Murray PR, Baron E, Jorgensen J, et al. Manual of Clinical Microbiology. 9th Edition, ASM Press. Washington, DC. 2007.
3. Levine DP. Vancomycin: a history. Clin Infect Dis 2006;42:5-12.
4. Nishino Y, Takemura S, Minamiyama Y, et al. Targeting superoxide dismutase to renal proximal tubule cells attenuates vancomycin-induced nephrotoxicity in rats. Free Radic Res 2003;37:373-9.
5. Qu S, Dai C, Lang F, et al. Rutin attenuates vancomycininduced nephrotoxicity by ameliorating oxidative stress, apoptosis, and inflammation in rats. Antimicrob Agents Chemother 2019;63: e01545-18.
6. Oktem F, Arslan MK, Ozguner F, et al. In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine. Toxicology 2005;215:227-33.
7. Sommerburg O, Keunen JE, Bird AC, et al. Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol 1998; 82:907-10.
8. Du SY, Zhang YL, Bai RX, et al. Lutein prevents alcoholinduced liver disease in rats by modulating oxidative stress and inflammation. Int J Clin Exp Med 2015;8: 8785-93.
9. Ohkawa H, Ohishi N and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8.
10. Sedlak J and Lindsay RH. Estimation of total, proteinbound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968; 25:192-205.
11. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103-11.
12. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:112-9.
13. Baud L and Ardaillou R. Reactive oxygen species: production and role in the kidney. Am J Physiol 1986;25:765-76.
14. Pfaller W and Gstraunthaler G. Nephrotoxicity testing in vitro--what we know and what we need to know. Environ Health Perspect 1998;106:559-69.
15. Davies K and Goldberg A. Oxygen radicals stimulate intracellular proteolysis and lipid peroxidation by independent mechanisms in erythrocytes. J Biol Chem 1987;262:8220-6.
16. Goulart M, Batoreu M, Rodrigues A, et al. Lipoperoxidation products and thiol antioxidants in chromium exposed workers. Mutagenesis 2005;20:311-5.
17. King DW and Smith MA. Proliferative responses observed following vancomycin treatment in renal proximal tubule epithelial cells. Toxicol In Vitro 2004;18:797-803.
18. Ichikawa I, Kiyama S and Yoshioka T. Renal antioxidant enzymes: their regulation and function. Kidney Int 1994;45:1-9.
19. Young SG and Parthasarathy S. Why are low-density lipoproteins atherogenic? West J Med 1994;160:153- 64.
20. Cheeseman K and Slater T. An introduction to free radical biochemistry. Br Med Bull 1993;49:481-93.
21. Bayomy NA, Abdelaziz EZ, Said MA, et al. Effect of pycnogenol and spirulina on vancomycin-induced renal cortical oxidative stress, apoptosis, and autophagy in adult male albino rat. Can J Physiol Pharmacol 2016;94:838-48.
22. Pizzorno J. Glutathione! Integr Med (Encinitas) 2014;13:8-12.
23. Esterbauer H, Gebicki J, Puhl H, et al. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992;13:341-90.
24. Vasudeva V, Tenkanidiyoor YS, Radhakrishna V, et al. Palliative effects of lutein intervention in gammaradiation-induced cellular damages in Swiss albino mice. Indian J Pharmacol 2017;49:26-33.
25. Sindhu ER and Kuttan R. Carotenoid lutein protects the kidney against cisplatin-induced acute renal failure. J Environ Pathol Toxicol Oncol 2013;32:21-8.
26. Liu ZG, Qi ZC, Liu WL, et al. Lutein protects against ischemia/reperfusion injury in rat kidneys. Mol Med Rep 2015;11:2179-84.
27. Bayram A, Erkan GN, Talih G, et al. The alpha-2 receptor agonist dexmedetomidine attenuates vancomycin induced acute kidney injury. Bratisl Lek Listy 2019;120:429-33.
28. AbuBakr HO, Aljuaydi SH, Abou-Zeid SM, et al. Burninduced multiple organ injury and protective effect of lutein in rats. Inflammation 2018;41:760-72.
29. Cetin H, Olgar S, Oktem F, et al. Novel evidence suggesting an anti-oxidant property for erythropoietin on vancomycin-induced nephrotoxicity in a rat model. Clin Exp Pharmacol Physiol 2007;34:1181-5.
30. Sener MT, Sener E, Tok A, et al. Biochemical and histologic study of lethal cisplatin nephrotoxicity prevention by mirtazapine. Pharmacological Reports 2012;64:594-602.